| Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
| SEMORINEMAB | Antibody | none | Microtubule-associated protein tau inhibitor | 2 | ['Completed', 'Terminated', 'Active, not recruiting'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| GOSURANEMAB | Antibody | none | Microtubule-associated protein tau inhibitor | 2 | ['Terminated', 'Completed', 'Terminated', 'Terminated'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| TILAVONEMAB | Antibody | none | Microtubule-associated protein tau inhibitor | 2 | ['Terminated', 'Terminated', 'Completed', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| BEPRANEMAB | Antibody | none | Microtubule-associated protein tau inhibitor | 2 | ['Completed', 'Active, not recruiting', 'Active, not recruiting'] | ['ClinicalTrials', 'ClinicalTrials', 'ClinicalTrials'] |
| ZAGOTENEMAB | Antibody | none | Microtubule-associated protein tau inhibitor | 2 | ['Completed', 'Completed'] | ['ClinicalTrials', 'ClinicalTrials'] |
| POSDINEMAB | Antibody | none | Microtubule-associated protein tau inhibitor | 1 | ['Completed'] | ['ClinicalTrials'] |